Adicet Bio (Series A)

Funding Details
Awarder
Inbox
Date Award
January 27, 2016
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$51,000,000

Company Info
Organizations Involved
Novartis Venture Funds, Johnson & Johnson Innovation, Regeneron Pharmaceuticals
Founders
Aya Jakobovits
Company Description
Adicet Bio, Inc. is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies for cancer and other disease indications, with a focus on novel universal immune cell therapies (uICT).
Market
Cancer immunotherapy
Location
Menlo Park, California, USA
Coinvestors
Novartis Venture Funds, OrbiMed Advisors, Pontifax

Links